Company / Interest Expense per Share
10x Genomics, Inc. Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
$0.00 / $0.01
FY2019-FY2023
Trend
-93.2%
vs FY2022
Sector context
#41 of 40
Health Care
What the data says
Among 40 Health Care companies, 10x Genomics, Inc. is in the top -2% for interest expense per share. Interest Expense per Share has declined for 4 consecutive years, from $0.21 in FY2019 to $0.00 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -72.4%.
Improved from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -74.6%
- 5-Year CAGR
- -72.4%
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 40This company $0.00 Sector average $1.56
▼
-100.0% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s interest expense per share has declined for 4 consecutive years.
- In FY2023, interest expense per share decreased 93.2% year-over-year.
- Ranks #41 out of 40 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -93.2% |
| FY2022 | $0.00 | -47.0% |
| FY2021 | $0.01 | -54.3% |
| FY2020 | $0.02 | -91.7% |
| FY2019 | $0.21 | +17.6% |
| FY2018 | $0.18 | +157.0% |
| FY2017 | $0.07 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026